AMRUTAJAN HEALTH LTD

AMRUTANJAN

Small Cap | Pharmaceuticals
₹548.55
-9.5 (-1.7%)

Stock price as on 08 May 2026 at 15:30 PM

Amrutajan health ltd share price update

As of the latest trading session, Amrutajan Health Ltd share price is currently at ₹548.55, which is down by ₹-9.5 from its previous closing. Today th...

Amrutajan Health Ltd stock performance

Today’s low

₹542

Today’s high

₹570

₹548.55

52 week low

₹486

52 week high

₹790.95

₹548.55
Open
₹555.00
Previous close
₹558.05
Share volume
17,862
Total traded value (Lakh)
₹97.98
Upper circuit
₹669.65
Lower circuit
₹446.45

Amrutajan Health Ltd fundamentals

Market cap (Cr)
₹1,585.90
P/E ratio (TTM)
27.89
Book value per share
₹118.31
Beta
0.59
Return on equity
16.53%
Earnings per share (TTM)
₹20.00
Dividend yield
0%
Net profit/quarter (Cr)
₹16.19

Amrutajan Health Ltd technical summary

₹548.55
-1.7 ▼
15
Bearish
1
Bullish
5 Day554.4
10 Day557.7
12 Day557.6
20 Day555.3
26 Day554.5
50 Day561.7
100 Day588.9
200 Day627.6
5 Day552.2
10 Day565.4
12 Day567.1
20 Day556.4
26 Day545.9
50 Day550.6
100 Day593.7
200 Day650.9

554.88

PIVOT

First support
₹546.97
First resistance
₹565.97
Second support
₹535.88
Second resistance
₹573.88
Third support
₹527.97
Third resistance
₹584.97
RSI
47.65
ADX
23.7
MACD
3.09
Williams % R
-68.37
Commodity Channel Index (CCI)
-13.07
Date
08 May 2026
Same day
9,444
Week
26,680
Month
16,231
1 year
0.6
3 years
0.67
Over 1 month
2.8%
Over 1 year
-21.45%
Over 3 months
-13.3%
Over 3 years
-2.44%
Over 6 months
-22.08%
Over 6 years
-2.96%

Investment Returns

Over 1 Month2.8%
Over 3 Months13.3%
Over 6 Months22.08%
Over 1 Year21.45%

Amrutajan Health Ltd Shareholding pattern


Public
38.64%
Promoter holdings
46.51%
FII
2.17%
DII
12.66%
Promoter shares
0%
Promoter sharesShareCategory

Goodhealth Holdings Private Limited

58,25,803 (20.15%)

Shareholding of Promoter and Promoter Group

Sambhuprasad Sivalenka

29,90,730 (10.34%)

Shareholding of Promoter and Promoter Group

Dsp Small Cap Fund

14,15,225 (4.9%)

Public Shareholding

Ramaa Prabhakar Arikirevula

13,71,530 (4.74%)

Shareholding of Promoter and Promoter Group

Sambhu Prasad Sivalenka

10,40,171 (3.6%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Goodhealth Holdings Private Limited58,25,803 (20.15%)Shareholding of Promoter and Promoter Group
Sambhuprasad Sivalenka29,90,730 (10.34%)Shareholding of Promoter and Promoter Group
Dsp Small Cap Fund14,15,225 (4.9%)Public Shareholding
Ramaa Prabhakar Arikirevula13,71,530 (4.74%)Shareholding of Promoter and Promoter Group
Sambhu Prasad Sivalenka10,40,171 (3.6%)Shareholding of Promoter and Promoter Group
Ramaa Prabhakar Arikirevula8,72,535 (3.02%)Shareholding of Promoter and Promoter Group
Carnelian Bharat Amritkaal Fund .8,60,403 (2.98%)Public Shareholding
Ramalingam Ganti7,30,640 (2.53%)Shareholding of Promoter and Promoter Group
Amulya Kamakshi Priya Arikirevula6,16,781 (2.13%)Shareholding of Promoter and Promoter Group
Icici Prudential Fmcg Fund6,10,223 (2.11%)Public Shareholding
Dipak Kanayalal Shah3,24,036 (1.12%)Public Shareholding
Carnelian Structural Shift Fund3,15,000 (1.09%)Public Shareholding

About AMRUTAJAN HEALTH LTD

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. Th

Parent Organisation

Amrutanjan Group

NSE Symbol

AMRUTANJAN

Founded

1936

AMRUTAJAN HEALTH LTD CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
18 Nov 20251Interim 118 Nov 2025Equity shares
16 Sept 20252.6Final16 Sept 2025Equity shares
18 Feb 20251Interim 218 Feb 2025Equity shares
22 Nov 20241Interim 122 Nov 2024Equity shares
13 Sept 20242.6Final17 Sept 2024Equity shares
20 Feb 20241Interim 220 Feb 2024Equity shares
23 Nov 20231Interim 123 Nov 2023Equity shares
14 Sept 20232.6Final14 Sept 2023Equity shares
24 Feb 20231Interim 224 Feb 2023Equity shares
14 Nov 20221Interim 115 Nov 2022Equity shares
14 Sept 20222.6Final16 Sept 2022Equity shares
18 Feb 20221Interim 221 Feb 2022Equity shares
16 Nov 20211Interim 117 Nov 2021Equity shares
15 Sept 20212.6Final16 Sept 2021Equity shares
17 Feb 20210.8Interim 219 Feb 2021Equity shares
19 Nov 20200.8Interim 120 Nov 2020Equity shares
18 Feb 20201.55Interim 221 Feb 2020Equity shares
15 Nov 20190.55Interim 118 Nov 2019Equity shares
17 Sept 20191.05Final19 Sept 2019Equity shares
20 Feb 20190.55Interim 221 Feb 2019Equity shares
12 Nov 20180.55Interim 113 Nov 2018Equity shares
07 Sept 20180.85Final11 Sept 2018Equity shares
22 Feb 20181.1Interim 223 Feb 2018Equity shares
16 Nov 20171.1Interim 117 Nov 2017Equity shares
13 Sept 20171.65Final14 Sept 2017Equity shares
16 Feb 20171.1Interim 217 Feb 2017Equity shares
17 Nov 20161.1Interim 118 Nov 2016Equity shares
18 Mar 20162.65Interim 221 Mar 2016Equity shares
17 Feb 20161.2Interim19 Feb 2016Equity shares
10 Sept 20152.4Final12 Sept 2015Equity shares
13 Feb 20151.1Interim17 Feb 2015Equity shares
17 Sept 20142.2Final19 Sept 2014Equity shares
17 Feb 20141Interim19 Feb 2014Equity shares
02 Aug 20132Final06 Aug 2013Equity shares
21 Feb 20131Interim22 Feb 2013Equity shares
20 Sept 201210Final24 Sept 2012Equity shares
23 Feb 20125Interim24 Feb 2012Equity shares
12 Sept 201110Final14 Sept 2011Equity shares
21 Feb 20115Interim22 Feb 2011Equity shares
13 Aug 201010Final17 Aug 2010Equity shares
09 Feb 20105Interim10 Feb 2010Equity shares
16 Sept 200912Final18 Sept 2009Equity shares
04 Feb 20095Interim05 Feb 2009Equity shares
08 Sept 20083Final10 Sept 2008Equity shares
28 Jul 200840Interim29 Jul 2008Equity shares
05 Feb 20084Interim06 Feb 2008Equity shares
03 Aug 20072Final07 Aug 2007Equity shares
24 Jan 20074Interim25 Jan 2007Equity shares
29 Jul 20050Final02 Aug 2005Equity shares
14 Feb 20050Interim15 Feb 2005Equity shares

View more stocks

What’s trending

All stocks

NAKSH

NAKSH PRECIOUS METALS LIMITED

4.5
+0.75 (+20%)
ASTALLTD

ASTAL LABORATORIES LIMITED

89.05
+14.84 (+20%)
GSTL-X

GLOBALSPACE TECHNOLOGIES LIMIT

33.48
+5.58 (+20%)
FROG

FROG INNOVATIONS LIMITED

189.7
+31.6 (+19.99%)
View all

Top gainers

TITAN

TITAN COMPANY LIMITED

4509
+201.50 (+4.68%)
APOLLOHOSP

APOLLO HOSPITALS ENTER. L

8097
+260.00 (+3.32%)
ASIANPAINT

ASIAN PAINTS LIMITED

2599.9
+69.30 (+2.74%)
TATACONSUM

TATA CONSUMER PRODUCT LTD

1176.2
+24.50 (+2.13%)
View all

Top losers

SBIN

STATE BANK OF INDIA

1019.3
-72.70 (-6.66%)
COALINDIA

COAL INDIA LTD

456.4
-10.25 (-2.20%)
HDFCBANK

HDFC BANK LTD

780.85
-15.20 (-1.91%)
AXISBANK

AXIS BANK LIMITED

1268.3
-24.40 (-1.89%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)